DV

Deleshwari Vijay Harinkhede

Active Director Director DIN 11354690
DIN 11354690 First appointment Oct 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Deleshwari Vijay Harinkhede

Data last updated:

Deleshwari Vijay Harinkhede is a Director at Al Baith Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11354690
Primary Designation Director
Industry Pharma
First Appointment 25 Oct 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Oct 20252025Active

Board colleagues of Deleshwari Vijay Harinkhede

NameDINCompanyDesignation
Zareen Rizwan Khan11354691Al Baith Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Al Baith Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Deleshwari Vijay Harinkhede

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deleshwari Vijay Harinkhede

Deleshwari Vijay Harinkhede currently holds 1 directorship: Al Baith Pharmaceuticals Private Limited (Director, since 25 Oct 2025).

Deleshwari Vijay Harinkhede was first appointed on 25 Oct 2025 as Director at Al Baith Pharmaceuticals Private Limited.

The current boards of Deleshwari Vijay Harinkhede's companies include Zareen Rizwan Khan (Al Baith Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available